Location Philadelphia, Pennsylvania, United States Regions Greater Philadelphia Area, Great Lakes, Northeastern US Gender Male
Website www.bioclinica.com/ LinkedIn View on LinkedIn
Dr. John Hubbard is the President and CEO of Bioclinica. He is a leader in the Clinical Services and Biopharmaceutical R&D industries, with over three decades of experience including executive level positions at Pfizer, ICON, Parexel and Hoechst Marion Roussel Pharmaceuticals.
Prior to joining Bioclinica, he was Senior Vice President and
Worldwide Head of Development Operations for Pfizer, where he directed and oversaw clinical trial operations and management of more than 450 clinical projects. Dr. Hubbard was also a founding member of the Board of Directors of TransCelerate Biopharma, Inc. Before joining Pfizer, Dr. Hubbard was Group President, Clinical Research Services at ICON Clinical Research, a top five global clinical research organization. He is also a Board Member of Agile Therapeutics, a Board Member of the Association of Clinical Research Organizations (ACRO), and an Advisory Board Member and Fundraising Vice-chair for the Children's Brain Tumor Foundation.
Dr. Hubbard received a Bachelor of Science degree in Biopsychology from the University of Santa Clara and a Doctorate from the University of Tennessee, with a research focus on the genetic basis of hypertension and autonomic dysfunction. He was an NIH Postdoctoral Fellow in Cardiovascular and Clinical Pharmacology at the University of Texas Health Sciences Center.
